These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17956297)

  • 1. Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities.
    Motterlini R
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1142-6. PubMed ID: 17956297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive properties of iron-containing carbon monoxide-releasing molecules.
    Sawle P; Hammad J; Fairlamb IJ; Moulton B; O'Brien CT; Lynam JM; Duhme-Klair AK; Foresti R; Motterlini R
    J Pharmacol Exp Ther; 2006 Jul; 318(1):403-10. PubMed ID: 16603670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models.
    Ryter SW; Choi AM
    Novartis Found Symp; 2007; 280():165-75; discussion 175-81. PubMed ID: 17380794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.
    Chatterjee PK
    Br J Pharmacol; 2004 Jun; 142(3):391-3. PubMed ID: 15148242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs).
    Motterlini R; Sawle P; Hammad J; Mann BE; Johnson TR; Green CJ; Foresti R
    Pharmacol Res; 2013 Feb; 68(1):108-17. PubMed ID: 23253427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis.
    Lancel S; Hassoun SM; Favory R; Decoster B; Motterlini R; Neviere R
    J Pharmacol Exp Ther; 2009 May; 329(2):641-8. PubMed ID: 19190234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
    Desmard M; Foresti R; Morin D; Dagouassat M; Berdeaux A; Denamur E; Crook SH; Mann BE; Scapens D; Montravers P; Boczkowski J; Motterlini R
    Antioxid Redox Signal; 2012 Jan; 16(2):153-63. PubMed ID: 21864022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes.
    Alberto R; Motterlini R
    Dalton Trans; 2007 May; (17):1651-60. PubMed ID: 17443255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon monoxide is a poison... to microbes! CO as a bactericidal molecule.
    Chin BY; Otterbein LE
    Curr Opin Pharmacol; 2009 Aug; 9(4):490-500. PubMed ID: 19640789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon monoxide: mechanisms of action and potential clinical implications.
    Rochette L; Cottin Y; Zeller M; Vergely C
    Pharmacol Ther; 2013 Feb; 137(2):133-52. PubMed ID: 23026155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu2-alkyne dicobalt(0)hexacarbonyl complexes as carbon monoxide-releasing molecules (CO-RMs): probing the release mechanism.
    Atkin AJ; Williams S; Sawle P; Motterlini R; Lynam JM; Fairlamb IJ
    Dalton Trans; 2009 May; (19):3653-6. PubMed ID: 19417926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide.
    Bannenberg GL; Vieira HL
    Expert Opin Ther Pat; 2009 May; 19(5):663-82. PubMed ID: 19441940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide-releasing molecules: a pharmacological expedient to counteract inflammation.
    Alcaraz MJ; Guillen MI; Ferrandiz ML; Megías J; Motterlini R
    Curr Pharm Des; 2008; 14(5):465-72. PubMed ID: 18289073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of carbon monoxide-releasing molecules.
    Motterlini R; Mann BE; Foresti R
    Expert Opin Investig Drugs; 2005 Nov; 14(11):1305-18. PubMed ID: 16255672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of carbon monoxide as a therapeutic agent: promises and challenges.
    Foresti R; Bani-Hani MG; Motterlini R
    Intensive Care Med; 2008 Apr; 34(4):649-58. PubMed ID: 18286265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs).
    Motterlini R; Haas B; Foresti R
    Med Gas Res; 2012 Nov; 2(1):28. PubMed ID: 23171578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoactive metal carbonyl complexes as potential agents for targeted CO delivery.
    Gonzales MA; Mascharak PK
    J Inorg Biochem; 2014 Apr; 133():127-35. PubMed ID: 24287103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules.
    Motterlini R; Mann BE; Johnson TR; Clark JE; Foresti R; Green CJ
    Curr Pharm Des; 2003; 9(30):2525-39. PubMed ID: 14529551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose inhaled carbon monoxide attenuates the remote intestinal inflammatory response elicited by hindlimb ischemia-reperfusion.
    Scott JR; Cukiernik MA; Ott MC; Bihari A; Badhwar A; Gray DK; Harris KA; Parry NG; Potter RF
    Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G9-G14. PubMed ID: 19114681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for reactive oxygen species in the antibacterial properties of carbon monoxide-releasing molecules.
    Tavares AF; Nobre LS; Saraiva LM
    FEMS Microbiol Lett; 2012 Nov; 336(1):1-10. PubMed ID: 22774863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.